Login | Register
Profile | Log out
logo

  • Home
  • News
  • Opinion
  • Other
    • Market Updates
    • Explainers
    • Satire
  • About
  • Contact Us
    • Contact
    • Get Covered
    • Posting Guidelines
  • Subscribe
Submit An Article

Blog

  • Home
  •  
  • Blog



  • Most Read
  • Latest Comments
  • Blog
    • News

    RBA and ASIC up the ante on blockchain project, ASX writes off millions
    Public
  • Blog
    • Satire

    Australia to close borders to Omicron Persei 8
    Public
  • Blog
    • Opinion

    The New Criterion: will the listed sanitiser stocks clean up – or clean out – investors?
    Public
  • Blog
    • Opinion

    Is this the most hated company on the ASX?
    Public
  • Blog
    Opening a new frontier in treating Parkinson’s disease
    • Review
    • November 11, 2022
  • Tremors from the FTX collapse continue to be felt as DigitalX sells off 15% Bitcoin holdings
    • Review
    • January 10, 2023
  • AUDC stablecoin gathers momentum as Novatti confirms integration with XRP Ledger
    • Review
    • June 9, 2022
  • PharmAust completes dosing first cohort for MND treatment, patients respond positively
    • Review
    • January 6, 2023
  • Is this the most hated company on the ASX?
    • Review
    • August 16, 2019

Latest Articles

  • AML3D announces stronger FY26, with positive EBITDA reported in the second half
    AML3D announces stronger FY26, with positive EBITDA reported in the second half
    • News

  • Refurbished tech gives Harris Technology a second life
    Refurbished tech gives Harris Technology a second life
    • News

  • Imagion Biosystems Advances MagSense® Phase 2 Trial
    Imagion Biosystems Advances MagSense® Phase 2 Trial
    • News

  • Acrux-developed Menopause Hormone Therapy to enter Australian market
    Acrux-developed Menopause Hormone Therapy to enter Australian market
    • News

  • Evion Expands Critical Minerals Push with Nevada Fluorspar Option
    Evion Expands Critical Minerals Push with Nevada Fluorspar Option
    • News

  • Rex teams up with Etihad Airways to expand global connectivity
    • News

    Rex teams up with Etihad Airways to expand global connectivity

    In a bid to enhance travel options for passengers, Rex Airlines (ASX: REX) has confirmed a major partnership with Etihad Airways, one of the world’s leading airlines based in the United Arab Emirates. This collaboration between Rex and Etihad is set to give passengers in both Australia and abroad more flexibility with their travel in

    Read More
    Public
  • Defense Support and Auxiliary Equipment Market to Grow at 6.74% CAGR By 2029
    • News

    Defense Support and Auxiliary Equipment Market to Grow at 6.74% CAGR By 2029

    Technological advancements, geopolitical tensions, and military modernisation programs are the factors driving market in the forecast period 2025-2029. According to TechSci Research report, “Defense Support and Auxiliary Equipment Market – Global Industry Size, Share, Trends, Competition Forecast & Opportunities, 2029”, The Global Defense Support and Auxiliary Equipment Market stood at USD 153.85 Billion in 2023 and

    Read More
    Public
  • Mesoblast receives FDA support for accelerated approval pathway for heart failure treatment
    • News

    Mesoblast receives FDA support for accelerated approval pathway for heart failure treatment

    Biotech company Mesoblast (ASX: MSB) has received positive feedback from the US Food and Drug Administration (FDA) for a new heart failure treatment called rexlemestrocel-L. This treatment aims to help people with severe heart failure, particularly those who have reached the end stages of the condition. Heart failure affects millions of people worldwide, with many

    Read More
    Public
  • Archer Materials reduces size of biochip gFET chip by 97%
    • News

    Archer Materials reduces size of biochip gFET chip by 97%

    Semiconductor company Archer Materials (ASX: AXE) has achieved a major milestone in its Biochip technology development by significantly reducing the size of its gFET (graphene field-effect transistor) chip. This achievement resulted from redesigning the circuit layouts, leading to a substantial decrease in chip size that has the potential to increase its utility in medical diagnostics.

    Read More
    Public
  • Magic mushrooms company Tryp prepares for ASX listing via $14.3m backdoor merger with Exopharm
    • News

    Magic mushrooms company Tryp prepares for ASX listing via $14.3m backdoor merger with Exopharm

    Canadian biotech company Tryp Therapeutics (CSE: TRYP) is set to list on the ASX through a backdoor merger with genetic medicines developer Exopharm (ASX: EX1) in a $14.3 million acquisition agreement. Following this agreement, Exopharm will change its name to Tryp and re-list on the ASX. On completion of the Transaction (Completion), Exopharm will be

    Read More
    Public
  • US shares reverse from all-time highs, XJO to open lower
    • Market Update

    US shares reverse from all-time highs, XJO to open lower

    The XJO is expected to open lower this morning following a pullback in the U.S on Friday. Their futures have edged into the red this morning. We managed to break higher on Friday and make fresh highs once again, however, as usual, our new heights are being met with selling. The market remains indecisive and

    Read More
    Public
  • «
  • ‹
  • 107
  • 108
  • 109
  • 110
  • 111
  • ›
  • »

Login or register for free to access unlimited reading

Register Now!
  • News

  • Opinion

  • Satire

  • About

  • Contact Us

  • Subscribe

The content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.

Copyright © 2020 The Sentiment. All rights reserved.
Subscribe

Enter your email address below to subscribe to The Sentiment’s weekly newsletter, highlighting the top news, research, opinion and satire articles shaping ASX investor sentiment.

The Sentiment respects your privacy and will not spam you. View our privacy policy here.